Background {#Sec1}
==========

The most commonly used antidepressants today effectively improve symptoms of depression, but require at least 2 weeks to take therapeutic effect. In addition, about two-thirds of depressive patients do not respond to the currently available antidepressants and are prone to relapse \[[@CR1]\]. Therefore, the development of new, fast-acting antidepressants is particularly important for patients with depression-induced suicidal tendencies \[[@CR2]\].

Recent observations suggest that sub-anesthetic doses of ketamine produce rapid therapeutic effects in depressed patients and in animal models of depression \[[@CR3]--[@CR6]\]. These effects are characterized by a rapid onset of action (within hours) after a single dose, a lasting effect (1 week), as well as an efficacy in patients resistant to traditional antidepressant drugs \[[@CR7], [@CR8]\].

In a prior investigation, we found that the antidepressant effect of ketamine was related to the regulation of multiple microRNAs (miRNAs) in neurons \[[@CR9]\]. Recent studies have shown that circular RNA (circRNA) is rich in miRNA binding sites. CircRNA plays the role of an miRNA sponge in cells, thereby relieving the inhibitory effect of the miRNAs on their target genes and increasing the expression of these genes. The mechanism by which circRNA inhibits miRNAs to increase the expression of their target genes is called the competitive endogenous RNA (ceRNA) mechanism \[[@CR10], [@CR11]\].

Based on the previous reports, the aim of this study was to determine the effect of an antidepressant dose of ketamine on the expression of circRNAs in the hippocampus of rats and examine a possible circRNA-mediated mechanism for ketamine's action. This work may provide new perspectives on the development of circRNA as a possible drug target.

Methods {#Sec2}
=======

Animals {#Sec3}
-------

These experiments were conducted in male Sprague-Dawley rats (50 days old, 150--200 g), provided by Chengdu Dashuo biological technology Co., Ltd., China (experimental animal production license: SCXK Chengdu 2013--17). These rats were housed 5 per cage in standard cages (42 × 20 × 20 cm) in a room. Animals had access to food and water ad libitum during the experiment. The room was maintained at 25--26 °C with about 65% relative humidity, on a 12-h dark/light cycle (lights on at 7 am). All experiments were performed according to National Institute of Health (NIH) guidelines and approved by the ethics committee of Southwest Medical University (Approval number:20180306038).

Experimental design and procedure {#Sec4}
---------------------------------

After 1 week of adaptation, the rats were randomly divided into control and experimental group (12 rats/group). The rats in control group were daily injected with 0.9% saline, whereas the rats in experimental group received ketamine (15 mg/kg). All injections were done intraperitoneally for three consecutive days (the volume of injection was 1 ml/kg). The dose of ketamine used in this study was based on our previous study \[[@CR9]\]. On day 4, approximately 24 h after the last ketamine or saline injection, the rats were sacrificed by cervical dislocation, and their hippocampus tissues were dissected out for circRNA microarray analysis (*n* = 3/group) and for qRT-PCR (*n* = 6 /group). The hippocampus of 3 remaining rats per group were spare specimen according to the quality of hippocampus removed from rats.

CircRNAs analysis from microarray chip {#Sec5}
--------------------------------------

Relevant circRNAs were analyzed according to our previous approach \[[@CR12]\]. Hippocampus tissues(*n* = 3/group) were used for microarray assay to determine differentially expressed circRNA between the two groups. The microarray hybridization was performed based on the Arraystar's standard protocols, including purifying RNA, transcribing into fluorescent cRNA, and hybridizing onto the rat circRNA Arrays (Arraystar). Finally, the hybridized slides were washed, fixed and scanned to images by the Agilent Scanner G2505C. The Agilent Feature Extraction software (version 11.0.1.1) were used to analyze the acquired array images. The raw data were normalized and data analysis was further performed with the R software Limma package (Agilent Technologies). The statistical significance of differentially regulated circRNAs between the two groups was identified through screening fold change ≥2.0, *P* \< 0.05 and FDR \< 0.05.

Quantitative real-time PCR validation {#Sec6}
-------------------------------------

Hippocampus tissues(*n* = 6/group) were used for qRT-PCR validation. After RNA isolation, M-MLV reverse transcriptase (Invitrogen, USA) was used for synthesizing cDNA according to the manufacturer's instructions. Subsequently, we performed qRT-PCR using the ViiA 7 Real-time PCR System (Applied Biosystems, Foster City, CA, USA) in a total reaction volume of 10 μl, including 2 μl cDNA, 5 μl 2 × Master Mix, 0.5 μl PCR Forward Primer (10 μM), 0.5 μl PCR Reverse Primer (10 μM) and 2 μl double distilled water. The protocol was initiated at 95 °C for 10 min, then at 95 °C (10 s), 60 °C (60 s) for a total 40 cycles. β-actin was used as a reference. Results were harvested in three independent wells. For quantitative results, the relative expression level of each circRNA was calculated using 2^−ΔΔCt^ method.

Competing endogenous RNA analysis of differentially expressed circRNAs {#Sec7}
----------------------------------------------------------------------

The candidate miRNA binding sites were searched on the sequences of circRNAs and mRNAs, and the circRNA-miRNA-mRNA interaction were found by the overlapping of the same miRNA seed sequence binding site both on the circRNAs and the mRNA. The miRNA-mRNA interactions were predicted by Targetscan (<http://www.targetscan.org/>), while the miRNA binding sites were predicted by miRcode (<http://www.mircode.org/>).

GO and KEGG pathway analysis {#Sec8}
----------------------------

Gene Ontology (GO) analysis ([http://www.geneontology.org](http://www.geneontology.org/)) were conducted to construct meaningful annotation of genes and gene products in the organisms. The ontology includes molecular functions (MFs), biological processes (BPs) and cellular components (CCs). KEGG pathway analysis were also performed to harvest pathway clusters on the molecular interaction and reaction networks in differentially regulated genes. The -log10 (*p*-value) denotes enrichment score representing the significance of GO term enrichment and pathway correlations among differentially expressed genes.

Statistical analysis {#Sec9}
--------------------

The statistical package for the social sciences (SPSS) 11.0 was selected for statistical analysis. All data were expressed as mean ± SEM. The data from the circRNA microarray and qRT-PCR were analyzed by one-way ANOVA or multi-factorial ANOVA followed by Tukey's post hoc test. *P* values less than 0.05 with statistically significant differences.

Results {#Sec10}
=======

The expression profile of circRNAs in the rat hippocampus using microarray analysis and secondary validation from qRT-PCR {#Sec11}
-------------------------------------------------------------------------------------------------------------------------

The RNA concentration and purity of all samples meted the requirement (larger than 1.8 and an RNA concentration greater than 30 ng) for subsequent microarray detection of the circRNA expression profile.

As shown in Fig. [1](#Fig1){ref-type="fig"}, significantly different circRNAs were selected for hierarchical clustering analysis. The circRNA hierarchical clustering map not only displays circRNA expression, but also exhibits the expression change of a single circRNA from both groups. As shown in Table [1](#Tab1){ref-type="table"}, four circRNAs were upregulated and one was down-regulated in the hippocampus of rats treated with ketamine from circRNA microarray analysis (*p* \< 0.05), but only two of the five circRNAs were confirmed to be differentially expressed from qRT-PCR (Table [3](#Tab3){ref-type="table"}, *p* \< 0.05). As shown in Table [2](#Tab2){ref-type="table"}, the primers for the five different circRNAs were designed using Primer software 5.0. Fig. 1The hierarchical clustering plot of differentially expressed circRNAs (fold change ≥1.5, *p* \< 0.05). Red indicates circRNAs with high expression levels, and green represents circRNAs with low expression levels, the color depth (ranging from black to color) indicates different expression intensities. Each row in the figure indicates a different circRNA, and each column indicates a sample (T is the ketamine group and C is the vehicle group). The left side of the figure shows the circRNA clustering tree, whereas the top shows the hippocampal sample clustering tree Table 1Aberrantly expressed circRNAs in rat hippocampus revealed by microarray analysis (Fold change ≥2.0, *p* \< 0.05)circRNAFold ChangeRegulation*P*-valuerno_circRNA_0034605.98up0.001rno_circRNA_0149002.28up0.003rno_circRNA_0065652.11up0.010rno_circRNA_0131092.17up0.012rno_circRNA_0054422.01down0.012 Table 2A list of primers used for real-time PCRGeneBi-directional primer sequenceAnnealing temperature (°C)Primer length (bp)β-actin (Reference)Forward:5′CGAGTACAACCTTCTTGCAGC 3′Reverse: 5′ ACCCATACCCACCATCACAC 3'60202rno_circRNA_014900Forward:5′ CTTAGATGACCTGGAGAAGACCT 3′Reverse: 5′ TGACTTGGTGCTGTTGACTTTAG 3'60124rno_circRNA_013109Forward:5′ ATTATAGAGCTAATTACAACTTCCG 3′Reverse:5′ TTATCTGAAGCATGTTAAGACAATA 3'60105rno_circRNA_006565Forward:5′ CGACTTCAAAAGAGTTGTGGATT 3′Reverse: 5′ TTCTCCTCGTGAGCTTTTTTCTC 3'6054rno_circRNA_005442Forward:5′ ACCCCATGAGAAAGACCAGGTC 3′Reverse:5′ CTGCTCTCTTCAAGTGAAAGACATC 3′6060rno_circRNA_003460Forward:5′ CGCTAAGCATTTCTTTGGAA 3′Reverse: 5′ GTAGTGGGTGTAGGGAGGAGA 3′6076

Predicted miRNAs sponged by the two circRNAs and their corresponding target genes {#Sec12}
---------------------------------------------------------------------------------

As shown in Table [3](#Tab3){ref-type="table"}, the two circRNAs 014900 and 005442 collectively sponged ten miRNAs, namely, rno-miR-466b-5p, rno-miR-6332, rno-miR-6321, rno-miR-193a-5p, rno-miR-1224, rno-miR-323-5p, rno-miR-107-5p, rno-miR-135b-5p, rno-miR-135a-5p, and rno-miR-344b-5p. Each of these miRNAs has target genes that they endogenously regulate, as shown in Table [4](#Tab4){ref-type="table"}, the two circRNAs could indirectly regulate numerous target genes by their endogenous competition mechanism. Table 3qRT-PCR-confirmed expression of circRNAs in rat hippocampus and the predicted target miRNAscircRNAFold ChangeRegulation*P*-valuePredicted target miRNAsrno_circRNA_0149002.37up0.029rno-miR-466b-5prno-miR-6332rno-miR-6321rno-miR-193a-5prno-miR-1224rno_circRNA_0054422.72down0.010rno-miR-323-5prno-miR-107-5prno-miR-135a-5prno-miR-135b-5prno-miR-344b-5p Table 4Target genes regulated indirectly by the two differentially expressed circRNAs through miRNAscircRNASponged miRNAsGene SymbolGene Descriptionrno_circRNA_014900rno-miR-193a-5prno-miR-1224Nova1neuro-oncological ventral antigen 1rno-miR-193a-5prno-miR-6332Clasp1cytoplasmic linker associated protein 1miR-193a-5prno-miR-466b-5pRgs4, Mixl1regulator of G-protein signaling 4; Mix paired-like homeobox 1rno-miR-466b-5prno-miR-6332Usp37, RGD1566029, Zfp91, Zmiz1, Pbx1ubiquitin specific peptidase 37; similar to mKIAA1644 protein; zinc finger protein 91; zinc finger, MIZ-type containing 1; pre-B-cell leukemia homeobox 1rno-miR-466b-5prno-miR-1224Calcoco1calcium binding and coiled coil domain 1rno-miR-466b-5prno-miR-6321Brwd3, Nfat5, Cnot7, Camta1bromodomain and WD repeat domain containing 3; nuclear factor of activated T-cells 5, tonicity-responsive; CCR4-NOT transcription complex, subunit 7; calmodulin binding transcription activator 1rno-miR-6332rno-miR-1224Prpf4b, Hgs, Gtdc1, Dgkkpre-mRNA processing factor 4B;hepatocyte growth factor-regulated tyrosine kinase substrate; glycosyltransferase-like domain containing 1;diacylglycerol kinase kapparno-miR-6332rno-miR-6321RGD1562037, Usp24,Ssbp2similar to OTTHUMP00000046255; ubiquitin specific peptidase 24; single-stranded DNA binding protein 2rno-miR-6332rno-miR-6321rno-miR-466b-5pSsbp2, RGD1562037singe-stranded DNA binding protein 2; similar to OTTHUMP00000046255rno-miR-6332rno-miR-466b-5p rno-miR-1224Zfp91zinc finger protein 91rno_circRNA_005442rno-miR-107-5prno-miR-323-5pEps8,Rhot1epidermal growth factor receptor pathway substrate 8, ras homolog gene family, member T1rno-miR-107-5prno-miR-344b-5pHn1hematological and neurological expressed 1rno-miR-107-5prno-miR-135b-5pPtk2,Tiam1protein tyrosine kinase 2;T-cell lymphoma invasion and metastasis 1rno-miR-107-5prno-miR-135a(b)-5pSlc8a1,Man2a1,Tnpo1,Rgl1solute carrier family 8 (sodium/calcium exchanger), member 1; mannosidase, alpha, class 2A, member 1;transportin 1; ral guanine nucleotide dissociation stimulator,-like 1rno-miR-323-5prno-miR-344b-5pTomm6translocase of outer mitochondrial membrane 6 homolog (yeast)rno-miR-323-5pmiR-135a(b)-5pShisa7shisa family member 7rno-miR-344b-5pmiR-135a(b)-5pArel1apoptosis resistant E3 ubiquitin protein ligase 1rno-miR-323-5prno-miR-107-5prno-miR-135a(b)-5pRhot1ras homolog gene family, member T1

GO analysis {#Sec13}
-----------

As shown in Fig. [2](#Fig2){ref-type="fig"}, the molecular functions (MFs) of neurons that may be regulated by the target genes of the differentially expressed circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). The classification of notable MFs was shown in Fig. [2](#Fig2){ref-type="fig"}a and b shows the order of these MFs by their GO analysis enrichment scores. Figure [2](#Fig2){ref-type="fig"}c shows the notable activities of neurons using fold enrichment. The detailed list of the genes identified as regulated by circRNA was shown in Additional files [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"}. Fig. 2The molecular functions (MFs) of neurons regulated by the target genes of the differentially expressed circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). **a** classifies the notable MFs and **b** shows these same MFs ordered by their GO analysis enrichment scores. **c** shows the notable activities of neurons that may be regulated by target genes predicted using fold enrichment

As shown in Fig. [3](#Fig3){ref-type="fig"}, the biological processes (BPs) in neurons that may be regulated by target genes of the two circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). The classification of notable BPs was shown in Fig. [3](#Fig3){ref-type="fig"}a and b shows the different BPs predicted by enrichment scores. Figure [3](#Fig3){ref-type="fig"}c shows the different BPs of neurons predicted using fold enrichment. The detailed list of the genes identified as regulated by circRNA was shown in Additional files [3](#MOESM3){ref-type="media"} and [4](#MOESM4){ref-type="media"}. Fig. 3The biological processes (BPs) in neurons regulated by target genes of the two circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). **a** classifies the predicted BPs and **b** shows the notable BPs predicted by enrichment scores. **c** shows the notable BPs of neurons that may be regulated by target genes predicted using fold enrichment

As shown in Fig. [4](#Fig4){ref-type="fig"}, the cellular components (CCs) that may be regulated by target genes of the two differentially expressed circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). The classification of notable CCs was shown in Fig. [4](#Fig4){ref-type="fig"}a and b shows the different CCs predicted by enrichment scores. Figure [4](#Fig4){ref-type="fig"}c shows the different CCs of neurons using fold enrichment. The detailed list of the genes identified as regulated by circRNA was shown in Additional files [5](#MOESM5){ref-type="media"} and [6](#MOESM6){ref-type="media"}. Fig. 4The cellular components (CCs) that may be regulated by target genes of the two differentially expressed circRNAs (*p* \< 0.05, left: rno_circRNA_014900; right: rno_circRNA_005442). **a** classifies the predicted CCs and **b** shows the notable CCs predicted by enrichment scores. **c** shows the notable CCs of neurons that may be regulated by target genes predicted using fold enrichment

KEGG pathway analysis {#Sec14}
---------------------

Tables [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"} shows the signaling pathways that may be regulated by target genes of the differentially expressed rno_circRNA_014900 and rno_circRNA_005442 (*p* \< 0.05). The identified pathways were involved in the regulation of central nervous system functions, such as Wnt signaling, long-term depression, PI3K-Akt signaling, dopaminergic synapse activity, mTOR signaling, p53 signaling, apoptosis, TGF-beta signaling, axon guidance, hippo signaling, and MAPK signaling. Table 5The signaling pathways that may be regulated by targeted genes of the differentially expressed rno_circRNA_014900(*p* \< 0.05)PathwayIDDefinitionFisher-PvalueEnrichment_Scorerno04510Focal adhesion - *Rattus norvegicus* (rat)4.05765E-065.391726rno05205Proteoglycans in cancer - Rattus norvegicus (rat)0.0002637393.578826rno05200Pathways in cancer - Rattus norvegicus (rat)0.0008394843.075988rno04216Ferroptosis - Rattus norvegicus (rat)0.0009476623.023347rno04015Rap1 signaling pathway - Rattus norvegicus (rat)0.0012424672.905715rno00564Glycerophospholipid metabolism - Rattus norvegicus (rat)0.0017677382.752582rno04310Wnt signaling pathway - Rattus norvegicus (rat)0.0025335462.596271rno05165Human papillomavirus infection - Rattus norvegicus (rat)0.0032139762.492957rno04140Autophagy - animal - Rattus norvegicus (rat)0.004641052.333384rno05222Small cell lung cancer - Rattus norvegicus (rat)0.0050317872.298278rno04070Phosphatidylinositol signaling system - Rattus norvegicus (rat)0.0064612452.189684rno00561Glycerolipid metabolism - Rattus norvegicus (rat)0.007917852.101393rno04213Longevity regulating pathway - multiple species - Rattus norvegicus (rat)0.007917852.101393rno04730Long-term depression - Rattus norvegicus (rat)0.007917852.101393rno04151PI3K-Akt signaling pathway - Rattus norvegicus (rat)0.008742112.058384rno04512ECM-receptor interaction - Rattus norvegicus (rat)0.0095163692.021529rno04137Mitophagy - animal - Rattus norvegicus (rat)0.0099205582.003464rno04728Dopaminergic synapse - Rattus norvegicus (rat)0.012483821.903653rno04211Longevity regulating pathway - Rattus norvegicus (rat)0.012862841.890663rno04136Autophagy - other - Rattus norvegicus (rat)0.013465011.870793rno04150mTOR signaling pathway - Rattus norvegicus (rat)0.013588611.866825rno04115p53 signaling pathway - Rattus norvegicus (rat)0.014020181.853246rno04215Apoptosis - multiple species - Rattus norvegicus (rat)0.014929461.825956rno05214Glioma - Rattus norvegicus (rat)0.014963181.824976rno04270Vascular smooth muscle contraction - Rattus norvegicus (rat)0.024280631.61474rno01521EGFR tyrosine kinase inhibitor resistance - Rattus norvegicus (rat)0.025496391.593521rno05219Bladder cancer - Rattus norvegicus (rat)0.025806991.588263rno05224Breast cancer - Rattus norvegicus (rat)0.028508841.54502rno05166HTLV-I infection - Rattus norvegicus (rat)0.029253041.533829rno04066HIF-1 signaling pathway - Rattus norvegicus (rat)0.031885941.496401rno04068FoxO signaling pathway - Rattus norvegicus (rat)0.034903391.457132rno04144Endocytosis - Rattus norvegicus (rat)0.035992591.443787rno04720Long-term potentiation - Rattus norvegicus (rat)0.038564421.413813rno04978Mineral absorption - Rattus norvegicus (rat)0.040455321.393024rno04725Cholinergic synapse - Rattus norvegicus (rat)0.042728071.369287rno05030Cocaine addiction - Rattus norvegicus (rat)0.043273091.363782rno04010MAPK signaling pathway - Rattus norvegicus (rat)0.043463331.361877rno04120Ubiquitin mediated proteolysis - Rattus norvegicus (rat)0.046674431.330921rno00062Fatty acid elongation - Rattus norvegicus (rat)0.047689461.321578rno05211Renal cell carcinoma - Rattus norvegicus (rat)0.047758321.320951rno01522Endocrine resistance - Rattus norvegicus (rat)0.047984421.3189 Table 6The signaling pathways that may be regulated by targeted genes of the differentially expressed rno_circRNA_005442 (*p* \< 0.05)PathwayIDDefinitionFisher-PvalueEnrichment_Scorerno04350TGF-beta signaling pathway - Rattus norvegicus (rat)0.0020567452.68682rno04960Aldosterone-regulated sodium reabsorption - Rattus norvegicus (rat)0.0028060532.551904rno05231Choline metabolism in cancer - Rattus norvegicus (rat)0.00393632.404912rno05412Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Rattus norvegicus (rat)0.0050004792.300988rno04550Signaling pathways regulating pluripotency of stem cells - Rattus norvegicus (rat)0.0052514242.279723rno04218Cellular senescence - Rattus norvegicus (rat)0.0057478592.240494rno04360Axon guidance - Rattus norvegicus (rat)0.0057478592.240494rno05225Hepatocellular carcinoma - Rattus norvegicus (rat)0.0057478592.240494rno04144Endocytosis - Rattus norvegicus (rat)0.0067730322.169217rno00510N-Glycan biosynthesis - Rattus norvegicus (rat)0.0074105222.130151rno04390Hippo signaling pathway - Rattus norvegicus (rat)0.0096945872.013471rno04068FoxO signaling pathway - Rattus norvegicus (rat)0.015877841.799209rno04371Apelin signaling pathway - Rattus norvegicus (rat)0.020582891.686494rno04520Adherens junction - Rattus norvegicus (rat)0.025015451.601792rno05210Colorectal cancer - Rattus norvegicus (rat)0.025015451.601792rno04973Carbohydrate digestion and absorption - Rattus norvegicus (rat)0.025801681.588352rno04010MAPK signaling pathway - Rattus norvegicus (rat)0.038101851.419054rno05410Hypertrophic cardiomyopathy (HCM) - Rattus norvegicus (rat)0.042040271.376335rno05414Dilated cardiomyopathy (DCM) - Rattus norvegicus (rat)0.048325621.315823

Discussion {#Sec15}
==========

There are about 340 million patients suffering from depression around the world, and it is estimated that up to 1 million people die by depression-induced suicide every year. Therefore, depression has become a global public health problem \[[@CR13]\]. The major clinical drawback of currently available antidepressants is their slow onset (14 days on average) and poor effects \[[@CR1]\]. Therefore, the development of rapid-onset antidepressants is particularly important for patients suffering from major depressive disorder with suicidal tendency. The antidepressant effect of ketamine initiates quickly and is also effective in treating refractory depression \[[@CR7], [@CR8]\]. However, the psychosocial side effects induced by ketamine have restricted its use in the treatment of depression \[[@CR14]\]. An in-depth understanding of the mechanism of ketamine's rapid antidepressant effect can provide new targets for similar antidepressants.

Recent many researches have shown that many transcriptional products come from the non-coding RNA (ncRNA), including the microRNA (miRNA), long non-coding RNA (lncRNA), and circular RNA (circRNA), these ncRNAs can regulate gene expression at the DNA level, pre-transcriptional level, transcriptional level, post-transcriptional level, translational level, and post-translational level \[[@CR15]\]. Previous study from our group found that ketamine induced abnormal expression of miRNAs in the brain, and subsequent target gene and functional analysis revealed that this abnormal expression of miRNAs was closely related to the antidepressant effect of ketamine, but the therapeutic effect of antidepressants focusing on a single mechanism is poor due to the complex mechanism of major depressive disorder \[[@CR9]\]. Therefore, we believe that a single miRNA plays relatively weak role in the regulation of a specific target gene. It was hypothesized that a substance in the body that could gather several miRNAs regulated the same specific target gene, then the regulatory action on the specific target gene would be obviously increased. It was interesting that circRNAs, a novel type of non-coding RNAs \[[@CR15]\], were perceived as a rare curiosity to having a central regulatory role in RNA metabolism, and accumulating evidences suggested that circRNAs could function as miRNA sponges (the ceRNA mechanism), therefore, circRNA could relieve the inhibitory effect of miRNA on its target gene and increase the expression of the target gene \[[@CR10]--[@CR12]\].

Our results showed that the expression of rno_circRNA_014900 was significantly increased by ketamine, while the expression of rno_circRNA_005442 was obviously decreased. Since these two circRNAs were not investigated in previous studies on depression, we further investigated their regulated target genes and signaling pathways. Competing endogenous RNA analysis found that the rno_circRNA_014900 could sponge rno-miR-466b-5p, rno-miR-6332, rno-miR-6321, rno-miR-193a-5p and rno-miR-1224, whereas the rno_circRNA_005442 had the binding sites in rno-miR-323-5p, rno-miR-107-5p, rno-miR-135a-5p, rno-miR-135b-5p and rno-miR-344b-5p. In a prior investigation, we found that miR-206 was a critical novel gene for the expression of BDNF (brain-derived neurotrophic factor) induced by ketamine \[[@CR9]\], our experimental results were expected to be that the circRNA identified in this study would target the miRNA-206, but structural prediction analysis showed that the miRNAs sponged by rno_circRNA_014900 and rno_circRNA_005442 did not include miRNA-206, we thought rno_circRNA_014900 and rno_circRNA_005442 did not regulate the expression of miRNA-206, how ketamine affects the expression of miRNA-206 needs to be further explored in future research. Further prediction analysis revealed that rno_circRNA_014900 and rno_circRNA_005442 may inhibit up to four miRNAs closely related to depression. For example, the predicted target genes related to depression include NOVA1 (regulated by miR-193-5p and miR-1224) \[[@CR16]\], Rgs4 (regulated by miR-193-5p and miR-466b-5p) \[[@CR17]--[@CR20]\], zinc-finger protein (regulated by miR-6332, miR-466b-5p, and miR-1224) \[[@CR21]\], PBX1 (regulated by miR-466b-5p and miR-6332) \[[@CR22]\], SLC8A1 (regulated by miR-107-5p, miR-135a(b)-5p, and miR-135b-5p) \[[@CR23]\], PTK2 (regulated by miR-107-5p and miR-135b-5p) \[[@CR24]\], and Tiam1 (regulated by miR-107-5p and miR-135b-5p) \[[@CR25]\]. Therefore, we believed rno_circRNA_014900 or rno_circRNA_005442 could relieve the inhibitory effect of miRNA on its target gene and increase the expression of the target gene, the phenomenon needs to be further confirmed in future studies.

The results from GO analysis found that the the target genes of the two circRNAs regulated many molecular functions (including protein phosphatase binding, SUMO binding, Wnt-protein binding, etc.), biological processes (including adherens junction assembly, neuron projection morphogenesis, neurological processes, etc.), and cellular components (including dendritic spines, AMPA-glutamate receptor binding, neuronal cell body, etc.). The results from KEGG pathway prediction showed that the signaling pathways regulated by target genes of the two circRNAs included Wnt signaling, long-term depression, PI3K-Akt signaling, dopaminergic synapses, mTOR signaling, p53 signaling, apoptosis, MAPK signaling, TGF-beta signaling, axon guidance, Hippo signaling, etc.. These signaling pathways may be involved in the occurrence and development of depression, because some researches found that the Wnt signaling pathway played important roles in the depression-like behaviors \[[@CR26]--[@CR28]\], the PI3K-Akt signaling pathway was related to the rapid antidepressant-like effects of some drugs \[[@CR29]--[@CR33]\].

As we analyzed in other study about circRNAs \[[@CR12]\], novel therapies should include multiple genes and pathways due to the complex mechanisms of major depression disorder. Because many pathophysiological processes of stress-related depression were regulated by several miRNAs, therefore these miRNAs may be commom targets of antidepressant therapies. It was not difficult to understand that the increase in relevant circRNAs expression would enhance the translation of their target genes due to miRNA sponges, a down-expression in relevant circRNAs would result in the obvious silencing of downstream target genes. Therefore, in the future, artificial circRNA drugs will be developed to restore normal transcriptional regulation.

Conclusions {#Sec16}
===========

In summary, we found that ketamine treatment resulted in the abnormal expression of the two circRNAs in the hippocampus of rats, and these two circRNAs may be associated with stress-related depression disorders. CircRNAs should remain the focus of researches investigating antidepressant targets because they have considerable potential in the clinical treatment of stress-related depression. As an invaluable topic for future biomedical studies, we plan to screen for specific circRNAs in the context of depression and to examine their potential value in the diagnosis and treatment of this debilitating disorder.

Supplementary information
=========================

 {#Sec17}
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